Effects of Concomitant Antibiotics Use on Immune Checkpoint Inhibitor Efficacy in Cancer Patients

OBJECTIVE: Immune checkpoint inhibitors (ICIs) have changed the outcomes of a variety of cancers in an unprecedented manner. Gut microbiome plays a crucial regulatory role in the antineoplastic therapy of ICIs, which can be influenced by antibiotic (ABX) administration. In this efficacy evaluation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shuai, Geng, Shuai, Chen, Qian, Zhang, Chen, Cheng, Mengfei, Yu, Yang, Zhang, Shuo, Shi, Ning, Dong, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864310/
https://www.ncbi.nlm.nih.gov/pubmed/35223505
http://dx.doi.org/10.3389/fonc.2022.823705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864310/
https://www.ncbi.nlm.nih.gov/pubmed/35223505
http://dx.doi.org/10.3389/fonc.2022.823705

Ejemplares similares